These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36358235)

  • 1. Population Pharmacokinetics of Prophylactic Cefazolin in Cardiac Surgery with Standard and Minimally Invasive Extracorporeal Circulation.
    Šantavý P; Šíma M; Zuščich O; Kubíčková V; Michaličková D; Slanař O; Urbánek K
    Antibiotics (Basel); 2022 Nov; 11(11):. PubMed ID: 36358235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of three alternative prophylactic antibiotics during cardiac surgery with extracorporeal circulation.
    Santavy P; Kubickova V; Sima M; Urbanek K
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Jun; 167(2):208-211. PubMed ID: 35775358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population Pharmacokinetic Study of Cefazolin Used Prophylactically in Canine Surgery for Susceptibility Testing Breakpoint Determination.
    Cagnardi P; Di Cesare F; Toutain PL; Bousquet-Mélou A; Ravasio G; Villa R
    Front Pharmacol; 2018; 9():1137. PubMed ID: 30356800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetic model-based dosing proposal for ampicillin prophylaxis in cardiac surgery patients with cardiopulmonary bypass.
    Urbánek K; Šantavý P; Zuščich O; Kubíčková V; Michaličková D; Slanař O; Šíma M
    J Chemother; 2023 Nov; 35(7):614-622. PubMed ID: 36715134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefazolin prophylaxis in children undergoing cardiac surgery with the use of cardiopulmonary bypass-is the dosing correct?
    Jaworski R; Dzierzanowska-Fangrat K; Czajkowska A; Maruszewski B; Kansy A
    Eur J Cardiothorac Surg; 2021 Dec; 61(1):27-33. PubMed ID: 34269390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic characteristics and microbiologic appropriateness of cefazolin for perioperative antibiotic prophylaxis in elective cardiac surgery.
    Lanckohr C; Horn D; Voeller S; Hempel G; Fobker M; Welp H; Koeck R; Ellger B
    J Thorac Cardiovasc Surg; 2016 Aug; 152(2):603-10. PubMed ID: 27209020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass to optimize dosing regimens for children undergoing cardiac surgery.
    De Cock PA; Mulla H; Desmet S; De Somer F; McWhinney BC; Ungerer JP; Moerman A; Commeyne S; Vande Walle J; Francois K; Van Hasselt JG; De Paepe P
    J Antimicrob Chemother; 2017 Mar; 72(3):791-800. PubMed ID: 27999040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass in adult patients undergoing cardiac surgery.
    Asada M; Nagata M; Mizuno T; Uchida T; Takahashi H; Makita K; Arai H; Kijima S; Echizen H; Yasuhara M
    Eur J Clin Pharmacol; 2021 May; 77(5):735-745. PubMed ID: 33211137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose optimization of cefazolin in South African children undergoing cardiac surgery with cardiopulmonary bypass.
    Gebreyesus MS; Dresner A; Wiesner L; Coetzee E; Verschuuren T; Wasmann R; Denti P
    CPT Pharmacometrics Syst Pharmacol; 2024 Jul; ():. PubMed ID: 38962872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of Cefazolin in Patients With Obesity Undergoing Surgery Requiring Cardiopulmonary Bypass.
    Poltak J; Connors C; Wungwattana M; Nicolau D; Mercuro NJ; Liu J
    J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt B):2942-2947. PubMed ID: 35227575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and Interstitial Fluid Pharmacokinetics of Prophylactic Cefazolin in Elective Bariatric Surgery Patients.
    Ryan RL; Jackson D; Hopkins G; Eley V; Christensen R; Van Zundert AAJ; Wallis SC; Lipman J; Parker SL; Roberts JA
    Antimicrob Agents Chemother; 2022 Jul; 66(7):e0041922. PubMed ID: 35762797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic Cefazolin Dosing in Women With Body Mass Index >35 kg·m-2 Undergoing Cesarean Delivery: A Pharmacokinetic Study of Plasma and Interstitial Fluid.
    Eley VA; Christensen R; Ryan R; Jackson D; Parker SL; Smith M; van Zundert AA; Wallis SC; Lipman J; Roberts JA
    Anesth Analg; 2020 Jul; 131(1):199-207. PubMed ID: 32250982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peri-operative pharmacokinetics of cefazolin prophylaxis during valve replacement surgery.
    Alli A; Paruk F; Roger C; Lipman J; Calleemalay D; Wallis SC; Scribante J; Richards GA; Roberts JA
    PLoS One; 2023; 18(9):e0291425. PubMed ID: 37729151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of renal function on the pharmacokinetics and pharmacodynamics of prophylactic cefazolin in cardiothoracic surgery.
    Kosaka T; Hosokawa K; Shime N; Taniguchi F; Kokufu T; Hashimoto S; Fujiwara H; Yaku H; Sugioka N; Okada K; Fujita N
    Eur J Clin Microbiol Infect Dis; 2012 Feb; 31(2):193-9. PubMed ID: 21598071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Pharmacokinetic Model-Based Evaluation of Standard Dosing Regimens for Cefuroxime Used in Coronary Artery Bypass Graft Surgery with Cardiopulmonary Bypass.
    Alqahtani SA; Alsultan AS; Alqattan HM; Eldemerdash A; Albacker TB
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysis.
    Brill MJ; Houwink AP; Schmidt S; Van Dongen EP; Hazebroek EJ; van Ramshorst B; Deneer VH; Mouton JW; Knibbe CA
    J Antimicrob Chemother; 2014 Mar; 69(3):715-23. PubMed ID: 24214905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of Cefazolin and Vancomycin in Infants Undergoing Open-Heart Surgery With Cardiopulmonary Bypass.
    Ingrande J; Gutierrez K; Lemmens HJ; Verma A; Nicolau DP; Sutherland CA; Ramamoorthy C
    Anesth Analg; 2019 May; 128(5):935-943. PubMed ID: 30995208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of cefazolin in critically ill children infected with methicillin-sensitive Staphylococcus aureus.
    Salvador E; Oualha M; Bille E; Beranger A; Moulin F; Benaboud S; Boujaafar S; Gana I; Urien S; Zheng Y; Toubiana J; Briand C; Bustarret O; Geslain G; Renolleau S; Treluyer JM; Hirt D
    Clin Microbiol Infect; 2021 Mar; 27(3):413-419. PubMed ID: 32360445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cefazolin delivery via the cardiopulmonary bypass circuit priming solution in infants and children.
    Cies JJ; Moore WS; Parker J; Stevens R; Al-Qaqaa Y; Enache A; Chopra A
    J Antimicrob Chemother; 2019 May; 74(5):1342-1347. PubMed ID: 30689931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expected advantage of administering prophylactic antibiotics using target- concentration controlled infusion: Development of a new pharmacokinetic model of cefazolin.
    Kim KM; Jung J; Lee JM; Yang HS; Bang JY; Lee EK; Choi BM; Noh GJ
    Clin Exp Pharmacol Physiol; 2022 Jul; 49(7):731-739. PubMed ID: 35434816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.